Your Article Summary
See Latest ArticlesEuropean Approval for UCB's Cimzia
PharmExec, 06/29/09
Europe's drug watchdog has recommended EU approval of UCB's rheumatoid arthritis treatment Cimzia. UCB said that the drug will be made available in the Europe before the end of the year and is now only awaiting marketing authorisation from the EU. Cimzia belongs to a class of drugs that block an inflammatory protein known as a tumour necrosis factor.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi Pasteur obtains license from Syntiron to develop & commercialize vaccine to prevent Staphylococcus infections
Sanofi-aventis, 12/17/09
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Today in Drug/Product Alerts...keeping you current
Receive free subspecialty "5-minute updates" via email
Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09
Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09